The International Academy of Clinical Research (IAoCR) hosted its first ever Clinical Research Industry Leader Think Tank last month at the Carlton Club in Westminster. The main aim of the meeting was to share ideas and pioneer initiatives to shape best practice in clinical research training.
Industry leaders from many of the world’s leading CROs and pharmaceutical companies came together to share ideas and discuss ways of working together to introduce an industry-wide competence-based accreditation programme in order to create a more portable and flexible workforce. Speakers included Professor Andrew George, Chair of the UK’s National Research Ethics Advisors’ Panel and Sally Osmond, Executive Vice President and General Manager of INC Research, a leading CRO.
One discussion that proved particularly interesting was looking at the changing approach of the regulators who are taking a more risk-based approach to inspections and are increasingly requesting evidence of competence after training courses.
What will it take for the industry to accept proof of competence over experience?
This was a question that stimulated a great deal of debate led to an agreement that there needs to be a universal framework against which the performance of clinical research professionals can be verified to ensure they have the right skills, knowledge and behaviours irrespective of their experience.
Jacqueline Johnson North, CEO at IAoCR, explains: “As an industry, we constantly hear about the importance of experience, with many companies stipulating that any CRAs working on their trials must have at least two years’ experience. This prerequisite has effectively caused stagnation in the industry, with many talented graduates finding themselves unable to get a job in clinical research. The industry is slowly realising that it is losing its young, talented stars because it places greater emphasis on experience than competence. From our discussions at the Think Tank, we saw that many organisations are beginning to recognise the benefits that a competence-based accreditation could bring.”
The IAoCR will host the next Clinical Research Industry Leaders’ Think Tank at the British Consulate General in New York this autumn.
In addition, the IAoCR outlined plans to embed clinical research into university programmes with leading universities both in the UK and overseas. Participants in the Think Tank discussed sponsoring a structured internship programme for students, promoting clinical research as a career. IAoCR will also be approaching Parliamentarians to attend future Clinical Research Industry Leaders Think Tank meetings.
For more information, please visit www.iaocr.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.